Deposition characteristics of a new allergic rhinitis nasal spray (MP29‐02*) in an anatomical model of the human nasal cavity.

Keywords: Nasal Cavity; Allergic Rhinitis; Fluticasone; Fluticasone Propionate; Nasal Spray EN Nasal Cavity Allergic Rhinitis Fluticasone Fluticasone Propionate Nasal Spray 1 1 1 03/02/21 20150627 NES 150627 Background Intranasal sprays must be delivered to the nasal cavity in sufficient volume, appropriate viscosity and droplet size and with a technique that allows optimal retention, maximizes absorption from the mucosa, and the potential for maximum therapeutic effect. Nasal Cavity, Allergic Rhinitis, Fluticasone, Fluticasone Propionate, Nasal Spray Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity. [Extracted from the article]